Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Shares Repurchased (2020 - 2025)

Healthstream (HSTM) has disclosed Shares Repurchased for 6 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • Quarterly Shares Repurchased changed N/A to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.9 million through Dec 2025, up 33.28% year-over-year, with the annual reading at $30.0 million for FY2025, N/A changed from the prior year.
  • Shares Repurchased for Q4 2025 was $5.0 million at Healthstream, down from $6.9 million in the prior quarter.
  • The five-year high for Shares Repurchased was $19.7 million in Q1 2022, with the low at $1.6 million in Q3 2023.
  • Average Shares Repurchased over 4 years is $7.0 million, with a median of $5.0 million recorded in 2021.
  • Peak annual rise in Shares Repurchased hit 36.57% in 2021, while the deepest fall reached 36.57% in 2021.
  • Over 4 years, Shares Repurchased stood at $5.0 million in 2021, then plummeted by 37.36% to $3.1 million in 2022, then skyrocketed by 132.1% to $7.3 million in 2023, then crashed by 31.27% to $5.0 million in 2025.
  • According to Business Quant data, Shares Repurchased over the past three periods came in at $5.0 million, $6.9 million, and $7.3 million for Q4 2025, Q3 2025, and Q4 2023 respectively.